Literature DB >> 8085374

Characterization of SPf(66)n: a chimeric molecule used as a malaria vaccine.

M C López1, Y Silva, M C Thomas, A Garcia, M J Faus, P Alonso, F Martinez, G Del Real, C Alonso.   

Abstract

SPf66 is a chemically synthesized 45 amino acid peptide derived from fractions of four different proteins of Plasmodium falciparum (83, 55 and 35 kDa and CS, the circumsporozoite protein) that elicits a protective immune response against malaria. In this paper we show the characterization of the SPf(66)n in batch 9 to be used in a field trial in young children at Ifakara in Tanzania. The analysis of SPf(66)n indicates that it is highly soluble in water and that the amino acid composition and sequence corresponds to that designed for the synthesis of the polypeptide. The packed product has a molecular weight ranging from 10 to 25 kDa. It is pure, free of metallic contaminants, atoxic and stable at 4 degrees C. The antibodies raised against this product in rabbits recognize the individual antigenic determinants of the molecule and the native epitopes of merozoites.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8085374     DOI: 10.1016/0264-410x(94)90261-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine.

Authors:  F Pöltl-Frank; R Zurbriggen; A Helg; F Stuart; J Robinson; R Glück; G Pluschke
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

Review 2.  [Malarial antigens in the era of mRNA vaccines].

Authors:  Yannick Borkens
Journal:  Monatsschr Kinderheilkd       Date:  2022-07-14       Impact factor: 0.416

Review 3.  Malaria vaccines.

Authors:  R Amador; M E Patarroyo
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

4.  Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.

Authors:  Ivette Caro-Aguilar; Alexandra Rodríguez; J Mauricio Calvo-Calle; Fanny Guzmán; Patricia De la Vega; Manuel Elkin Patarroyo; Mary R Galinski; Alberto Moreno
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.